Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Targeted Marrow Radiation (TMI) Improves Therapeutic Efficacy of STAT3 Decoy Molecules By Augmenting Its Delivery and Immune Modulation in an AML Mouse Model

Srideshikan Sargur Madabushi, PhD, Darren Zuro, Yu-Lin SU, PhD, Paresh Vishwasrao, MSc, Jamison Brooks, B.S, Liliana E Parra, James F Sanchez, PhD, Jeffrey Wong, MD, Marcin Kortylewski, PhD, Susanta Hui, PhD, DABR.

Blood (2019) 134 (Supplement_1): 3929.

https://doi.org/10.1182/blood-2019-127470

Published: 2019

Journal Articles

Pharmacoeconomic Analysis of Ideal Vs. Actual Body Weight-Based Treatment for Adult Persons with Hemophilia Α

Ming Y. Lim, MBBChir,MA, Jeffrey A. Gilreath, PharmD, Paul F. Bray, MD, George M. Rodgers, MD PhD

Blood (2019) 134 (Supplement_1): 4684.

https://doi.org/10.1182/blood-2019-121679

Published: 2019

Journal Articles

Prophylaxis Dose Adjustment in Hemophilia a Using a New Version of Population Pharmacokinetics Estimation Model Based on Bayesian Procedure

José María Sánchez-Raga, MD, Maria Margalida Santandreu Estelrich, MD, Bernat Galmés Sureda, Antonio Palomero Massanet, Guiomar Puget, MD, Antonia Sampol, MD PhD, Mariana Canaro, PhD MD

Blood (2018) 132 (Supplement 1): 5014.

https://doi.org/10.1182/blood-2018-99-119385

Published: 2018

Journal Articles

Recombinant Von Willebrand Factor Administration: Dosing Considerations and Rapid Stabilization of Endogenous Plasma FVIII Levels in Patients with Severe Von Willebrand Disease

Joan Cox Gill, MD, Pier Mannuccio Mannucci, Margaret V. Ragni, MD MPH, Giancarlo Castaman, Flora Peyvandi, Bettina Ploder, Aaron Novack, Peter Chen, Arthur Sytkowski, Bruce Ewenstein

Blood (2017) 130 (Supplement 1): 3682.

https://doi.org/10.1182/blood.V130.Suppl_1.3682.3682

Published: 2017

Journal Articles

Autologous Stem Cell Transplant: A Cost Effective and Efficacious Treatment for Newly Diagnosed Multiple Myeloma

Seema Niphadkar, DO, Indumathy Varadarajan, MD, Tiffany Pompa, MD, Kevin Y Hou, MD, Kathleen Degen, MD, Mariola Vazquez-Martinez, MD, Stuthi Perimbeti, MD, Kristine Ward, MD, Maneesh Jain, MD, Michael Styler, MD

Blood (2016) 128 (22): 2358.

https://doi.org/10.1182/blood.V128.22.2358.2358

Published: 2016

Journal Articles

Prognostic Impact Of Body Mass Index (BMI) In Acute Myeloid Leukemia (AML)

Emmanuelle Kempf, Pierre Hirsch, Myriam Labopin, Christophe Marzac, MD, Jean-Yves Perrot, Françoise Isnard, MD, Jean-Pierre Marie, MD, Mohamad Mohty, MD, PhD, Ollivier Legrand, MD, PhD

Blood (2013) 122 (21): 2658.

https://doi.org/10.1182/blood.V122.21.2658.2658

Published: 2013

Journal Articles

Development Of a New Regimen Function For Cancer Chemotherapy With a Computerized Physician Order Entry System Aimed At Reducing The Burden On Doctors In Japan

Tsunehiko Komatsu, MD, PhD, Yuko Nishide Kimura, Yuji Takaba, Kensuke Okubo, MST, Tomotaka Ishii, Koichiro Yuji, MD, Masahiko Nakagawa

Blood (2013) 122 (21): 5578.

https://doi.org/10.1182/blood.V122.21.5578.5578

Published: 2013

Journal Articles

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Blood (2013) 122 (21): 1294.

https://doi.org/10.1182/blood.V122.21.1294.1294

Published: 2013

Journal Articles

Phase 1 Study of Radiosensitization Using Bortezomib in Patients with Relapsed Non-Hodgkin's Lymphoma Receiving Radioimmunotherapy

Rebecca L. Elstrom, MD, John P. Leonard, MD, Paul Christos, Peter Martin, MD, Daniel Lebovic, MD, Joseph Osborne, Stanley J. Goldsmith, June Greenberg, RN, Richard R. Furman, MD, Jia Ruan, MD, PhD, Ryan Putman, Erica Chapman, Madhu Mazumdar, Kent A. Griffith, Morton Coleman, MD, Mark S. Kaminski, MD

Blood (2012) 120 (21): 1636.

https://doi.org/10.1182/blood.V120.21.1636.1636

Published: 2012

Journal Articles

Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-Risk MDS and MDS/AML (PODAC).

Seunghoon Han, Jae-Ho Yoon, Seung-Ah Yahng, Seung-Hwan Shin, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Seok Lee, Chang-Ki Min, Hee-je Kim, Dong-Wook Kim, Jong-Wook Lee, MD, PhD, Woo-Sung Min, MD, PhD, Chong-Won Park, Dong-Seok Yim, Yoo-Jin Kim

Blood (2012) 120 (21): 3076.

https://doi.org/10.1182/blood.V120.21.3076.3076

Published: 2012

Journal Articles

Phase 1 Study of Radiosensitization Using Bortezomib in Patients with Relapsed Non-Hodgkin's Lymphoma Receiving Radioimmunotherapy,

Rebecca Elstrom, MD, John P. Leonard, MD, Stanley J. Goldsmith, Paul Christos, Peter Martin, Joseph Osborne, Daniel Lebovic, MD, Ramsey Abdallah, CRC, June Greenberg, Richard R. Furman, MD, Jia Ruan, MD, PhD, Kent A. Griffith, Morton Coleman, MD, Mark S. Kaminski, MD

Blood (2011) 118 (21): 3712.

https://doi.org/10.1182/blood.V118.21.3712.3712

Published: 2011

Journal Articles

A Cross-Sectional Study Comparing Variation in Body Surface Area and Chemotherapy Dosing in Pediatric Oncology Using Two Different Methods

Wasil Jastaniah, MBBS, FRCPC, Mohammed Aseeri, Pharm.D.

Blood (2008) 112 (11): 3969.

https://doi.org/10.1182/blood.V112.11.3969.3969

Published: 2008

Journal Articles

The Effect of Increasing CD34+ Cell Doses on Time to Engraftment after Autotransplantation for Hematologic Malignancies.

V. Singh, J. Krishnamurthy, O. Frankfurt, Andrew M Evens, DO, MS, J. Altman, L. Gordon, S. Singhal, M. Tallman, S. Williams, J. Winter, J. Mehta

Blood (2008) 112 (11): 1115.

https://doi.org/10.1182/blood.V112.11.1115.1115

Published: 2008

Journal Articles

Actual (ABW) or Ideal (IBW) Body Weight to Calculate CD34+ Cell Dose in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Myeloma?

J. Krishnamurthy, V. Singh, O. Frankfurt, Andrew M Evens, DO, MS, J. Altman, L. Gordon, S. Singhal, M. Tallman, S. Williams, J. Winter, J. Mehta

Blood (2008) 112 (11): 4455.

https://doi.org/10.1182/blood.V112.11.4455.4455

Published: 2008

Journal Articles

Cost-Minimization Analysis of Anti-D Immune Globulin Versus Intravenous Immune Globulin for the Initial Treatment of Immune Thrombocytopenic Purpura.

David A. Wetzel, PharmD, Michael D. Tarantino, MD

Blood (2006) 108 (11): 3305.

https://doi.org/10.1182/blood.V108.11.3305.3305

Published: 2006

Journal Articles

Retrospective Analysis of Weekly Administration of Bortezomib in Multiple Myeloma.

Hamid Sayar, MD, Fa-Chyi Lee, MD

Blood (2005) 106 (11): 5186.

https://doi.org/10.1182/blood.V106.11.5186.5186

Published: 2005

NARROW

Targeted Marrow Radiation (TMI) Improves Therapeutic Efficacy of STAT3 Decoy Molecules By Augmenting Its Delivery and Immune Modulation in an AML Mouse Model

Pharmacoeconomic Analysis of Ideal Vs. Actual Body Weight-Based Treatment for Adult Persons with Hemophilia Α

Prophylaxis Dose Adjustment in Hemophilia a Using a New Version of Population Pharmacokinetics Estimation Model Based on Bayesian Procedure

Recombinant Von Willebrand Factor Administration: Dosing Considerations and Rapid Stabilization of Endogenous Plasma FVIII Levels in Patients with Severe Von Willebrand Disease

Autologous Stem Cell Transplant: A Cost Effective and Efficacious Treatment for Newly Diagnosed Multiple Myeloma

Prognostic Impact Of Body Mass Index (BMI) In Acute Myeloid Leukemia (AML)

Development Of a New Regimen Function For Cancer Chemotherapy With a Computerized Physician Order Entry System Aimed At Reducing The Burden On Doctors In Japan

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Phase 1 Study of Radiosensitization Using Bortezomib in Patients with Relapsed Non-Hodgkin's Lymphoma Receiving Radioimmunotherapy

Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-Risk MDS and MDS/AML (PODAC).

Phase 1 Study of Radiosensitization Using Bortezomib in Patients with Relapsed Non-Hodgkin's Lymphoma Receiving Radioimmunotherapy,

A Cross-Sectional Study Comparing Variation in Body Surface Area and Chemotherapy Dosing in Pediatric Oncology Using Two Different Methods

The Effect of Increasing CD34+ Cell Doses on Time to Engraftment after Autotransplantation for Hematologic Malignancies.

Actual (ABW) or Ideal (IBW) Body Weight to Calculate CD34+ Cell Dose in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Myeloma?

Cost-Minimization Analysis of Anti-D Immune Globulin Versus Intravenous Immune Globulin for the Initial Treatment of Immune Thrombocytopenic Purpura.

Retrospective Analysis of Weekly Administration of Bortezomib in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only